C-Reactive Protein and Prediction of Coronary Heart Disease and Global Vascular Events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)
Author(s) -
Naveed Sattar,
Heather Murray,
Alex McConnachie,
Gerard J. Blauw,
Edward Bollen,
Brendan M. Buckley,
Stuart M. Cobbe,
Ian Ford,
Allan Gaw,
Michael E. Hyland,
J. Wouter Jukema,
Adriaan M. Kamper,
Peter W. Macfarlane,
Michael Murphy,
Chris J. Packard,
Ivan J. Perry,
David J. Stott,
Brian Sweeney,
C. Twomey,
Rudi G. J. Westendorp,
James Shepherd
Publication year - 2007
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.106.643114
Subject(s) - medicine , pravastatin , cardiology , hazard ratio , c reactive protein , myocardial infarction , body mass index , prospective cohort study , stroke (engine) , clinical endpoint , proportional hazards model , statin , cholesterol , confidence interval , randomized controlled trial , mechanical engineering , engineering , inflammation
The role of C-reactive protein (CRP) in predicting vascular events and response to statin therapy remains uncertain. Additional large prospective studies are required.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom